Bromelain for Exercise Recovery

Verdict: Weak, inconsistent evidence; benefit unproven

Bromelain is not a proven aid for exercise recovery. The handful of small human trials are inconsistent, with objective markers of muscle damage almost always showing no benefit, so any effect remains unconfirmed.

C 🟠 C Weak Evidence Published with Warning

🔬Why this grade7-layer evidence engine

The grade reflects a thin, conflicting evidence base. Only a few small randomized trials exist (n=15-39), and most tested multi-enzyme protease blends rather than isolated bromelain, so bromelain's own contribution cannot be separated. A direct head-to-head trial against ibuprofen (PMID 12466693) found neither treatment reduced delayed-onset muscle soreness, range-of-motion loss or torque deficit.

Where signals appear, they are modest and subjective. A protease blend preserved muscle strength (about +7.6%) and another trial preserved peak torque (PMID 17685720), and a cycling study reported lower perceived fatigue (PMID 25604346) — yet objective damage markers (creatine kinase, myoglobin, soreness) were consistently null across these studies. A 1992 animal study (PMID 1548991) showed better force recovery but is preclinical only.

Authorities do not back this use. Mayo Clinic states there is no good scientific evidence supporting bromelain for muscle soreness, the US FDA treats it merely as a GRAS food enzyme, and EFSA, the NHS, WHO and major sports-medicine bodies either reject related claims or do not address recovery at all. Heavy affiliate marketing further inflates expectations beyond the data.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.48
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
C · Published with Warning
Confidence
74%
Broadly consistent
Evidence level
E6
Multiple smaller RCTs (n<500)

How strongly each layer supports this effect

lower = less supportive
L2 PubMedPrimary literature
0.45
L5 Clinical bodiesAuthoritative stance
0.47
L1 ExamineGlobal benchmark
0.50
L3 MechanismPlausibility
0.50
L11 AI re-checkIndependent read
0.50
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.479
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 無高階證據可裁決
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (5)L2 · primary research & systematic reviews

Preliminary comparison of bromelain and Ibuprofen for delayed onset muscle soreness management
PMID: 12466693 2002 RCT (double-blind) n = 39
Finding: No differences among treatments were observed for any dependent variable at any time point; both bromelain and ibuprofen failed to reduce pain, ROM deficit or torque loss versus the control condition.
Effect size: Null — no significant between-group differences
View on PubMed
Effects of a protease supplement on eccentric exercise-induced markers of delayed-onset muscle soreness and muscle damage
PMID: 17685720 2007 RCT (double-blind) n = 20
Finding: Decrements to peak torque and average power after the eccentric bout were significantly attenuated (p<0.05) in the supplement group, but no significant differences were observed for CK or perceived muscle soreness.
🟠 Limited quality Effect size: Strength preservation significant; CK and soreness NS
View on PubMed
Effects of a protease supplement on eccentric exercise-induced markers of delayed-onset muscle soreness and muscle damage
PMID: 17685720 2008 隨機對照試驗 n = 20
Finding: Decrements to peak torque and average power after the eccentric bout were significantly attenuated (p<0.05) in the supplement group, but no significant differences were observed for CK or perceived muscle soreness.
🟠 Limited quality Effect size: Strength preservation significant; CK and soreness NS
View on PubMed
Acute protease supplementation effects on muscle damage and recovery across consecutive days of cycle racing (Shing et al., Eur J Sport Sci)
PMID: 25604346 2016 RCT (double-blind) n = 15
Finding: Bromelain supplementation reduced subjective feelings of fatigue (lower fatigue rating on day four) and showed a trend to maintain testosterone, but did not significantly alter objective markers of muscle damage versus placebo.
🟠 Limited quality Effect size: Subjective fatigue lower in bromelain group; damage markers NS
View on PubMed
Attenuation of contraction-induced skeletal muscle injury by bromelain
PMID: 1548991 1992 Animal Study
Finding: Bromelain-treated hamster muscles showed higher force recovery than untreated injured muscles at 3 and 14 days post-injury (e.g., 20.5 vs 18.2 N/cm-2 at day 14, p<0.05); mechanistic/preclinical only, not human exercise data.
🟠 Limited quality Effect size: Day 14 force 20.5 vs 18.2 N/cm-2 (p<0.05)
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Neutral
Bromelain (CAS Reg. No. 9001-00-7) ... ENZYME, FLAVOR ENHANCER, FLAVORING AGENT OR ADJUVANT, PROCESSING AID, TEXTURIZER; GRAS, 21 CFR 184.1024 source↗
L4b EU EFSA
Against
L4d TW TFDA / 衛福部
Neutral
酵素製劑屬食品添加物第(十七)類「其他」,可於各類食品中視實際需要適量使用,限於食品製造或加工必須時使用。 source↗
L5a NIH Office of Dietary Supplements
Cautious
L5b Mayo Clinic
Cautious
People use bromelain for muscle soreness, pain, burns, kidney stones, and many other conditions, but there is no good scientific evidence to support these uses. source↗
L5c Cleveland Clinic
Neutral
L5e Specialty Society (condition-mapped)
Not addressed
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬5 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-recovery-INT-bromelain-001 繁體中文版 →